Reply to Potential Issues With the Use of Teriparatide After Denosumab-Related Osteonecrosis of the Jaw

J Bone Miner Res. 2022 Oct;37(10):2046-2047. doi: 10.1002/jbmr.4656. Epub 2022 Aug 4.

Judith Everts-Graber^{1

2}, John-Patrik Burkhard^{3

4}, Benoît Schaller³, Stephan Reichenbach^{2

5}, Thomas Lehmann¹

¹ OsteoRheuma Bern, Bern, Switzerland.
² Department of Rheumatology and Immunology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
³ Department of Cranio-Maxillofacial Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
⁴ Spalt- und Kraniofaziales Zentrum, Praxis Prof. Obwegeser, Zürich, Switzerland.
⁵ Institute for Social and Preventive Medicine, University of Bern, Bern, Switzerland.

No abstract available

Publication types